[ICIQ-SF questionnaire in women with urinary incontinence].

The ICIQ-SF questionnaire is used for evaluation of clinical manifestations in patients with urinary incontinence (UI) alone and combination of UI with lower urinary tract symptoms as well as assessment of quality of life in females with UI. Our study with ICIQ-SF questionnaire showed that UI was present in 23.8% responders. UI once a week or less often was marked most frequently by 11.6% women from all the age groups. Any volume of UI was marked by 24.5% women, most frequent volumes of urine loss were 15.9% and 7.1% in all age groups. Stress UI was prevalent in all the age groups (52.6%), the rate of urgent UI declined with age of women (16.3%), mixed UI rate, on the contrary, increased with age (26.7%). Significant frequency and volume of urine loss have the highest influence on quality of everyday women's life. Mixed UI reduced quality of life more significantly than stress and urgent UI. Thus, in view of high prevalence of UI among women, low compliance of the patients, the ICIQ-SF questionnaire can be recommended to therapists, gynecologists and urologists of the outpatient clinics for detection of UI in women. Response to ICIQ-SF questionnaire is a simple, easy-to-make and cheap method of preliminary UI diagnosis and assessment of UI impact on quality of life.

[Solifenacin in the treatment of overactive bladder: results of a randomized double-blind, placebo-controlled study].

The article presents the results of the evaluation of clinical efficacy and safety of the M-cholinoblocker solifenacin in the treatment of symptoms of overactive bladder (OAB). The study included 24 women aged from 47 to 69 years with symptoms of OAB lasting more than 3 months. It is shown that solifenacin at a dose of 5 mg reduces the quality of urinary urgency, improves the condition according to assessment of degree of discomfort due to symptoms of the OAB, treatment satisfaction and condition of the bladder.